+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Citeline - Market Research Reports

Citeline's analysis, insight and consultancy services span drug, device, company, clinical trial and market intelligence. All services are delivered by an authoritative team of industry experts in key markets around the globe.

P&G Grooming Quits Counting Blades, Innovates In New Directions While Battling DTC Disruptors - Product Thumbnail Image

P&G Grooming Quits Counting Blades, Innovates In New Directions While Battling DTC Disruptors

  • Newsletter
  • August 2026
  • 3 Pages
  • Global
From
Novartis' New Oncology CEO Liz Barrett Charts A Course, But It Will Require Jump-Starting New Brands - Product Thumbnail Image

Novartis' New Oncology CEO Liz Barrett Charts A Course, But It Will Require Jump-Starting New Brands

  • Newsletter
  • August 2026
  • 4 Pages
  • Global
From
Cell And Gene Therapies Test New Waters In Pricing And Reimbursement - Product Thumbnail Image

Cell And Gene Therapies Test New Waters In Pricing And Reimbursement

  • Newsletter
  • August 2026
  • 4 Pages
  • Global
From
The Implant Files: EU Blamed For Regulatory Inadequacies The World Over While 'Wrath'- Behrendt Fumes - Product Thumbnail Image

The Implant Files: EU Blamed For Regulatory Inadequacies The World Over While 'Wrath'- Behrendt Fumes

  • Newsletter
  • August 2026
  • 3 Pages
  • Europe, Global
From
Keeping Up With “The Energizer Bunny”: US FDA Commissioner Gottlieb As A Boss - Product Thumbnail Image

Keeping Up With “The Energizer Bunny”: US FDA Commissioner Gottlieb As A Boss

  • Newsletter
  • August 2026
  • 3 Pages
  • United States
From
Thinking about using CMMI? Here are tips from the experts - Product Thumbnail Image

Thinking about using CMMI? Here are tips from the experts

  • Newsletter
  • August 2026
  • 9 Pages
  • Global
From
Unilever Seeks End To Litigation Over St. Ives Scrub, Plaintiffs' 'Fake Medical Condition' - Product Thumbnail Image

Unilever Seeks End To Litigation Over St. Ives Scrub, Plaintiffs' 'Fake Medical Condition'

  • Newsletter
  • August 2026
  • 2 Pages
  • Global
From
Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says - Product Thumbnail Image

Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says

  • Newsletter
  • August 2026
  • 3 Pages
  • United States
From
The Advantages Of Providing Access To Unlicensed Medicines - Product Thumbnail Image

The Advantages Of Providing Access To Unlicensed Medicines

  • Newsletter
  • August 2026
  • 4 Pages
  • Global
From
Regulatory headaches: Brexit's not the only thing you need to worry about - Product Thumbnail Image

Regulatory headaches: Brexit's not the only thing you need to worry about

  • Newsletter
  • August 2026
  • 3 Pages
  • Global
From
Bone Grafts and Substitutes - Product Thumbnail Image

Bone Grafts and Substitutes

  • Newsletter
  • August 2026
  • 75 Pages
  • Global
Molecular Diagnostics - Product Thumbnail Image

Molecular Diagnostics

  • Newsletter
  • August 2026
  • 100 Pages
  • Global
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • August 2026
  • 88 Pages
  • Global
Merck Steps Out Of Insulin Glargine Market, But Says It Remains Committed To Biosimilars - Product Thumbnail Image

Merck Steps Out Of Insulin Glargine Market, But Says It Remains Committed To Biosimilars

  • Newsletter
  • August 2026
  • 3 Pages
  • Global
From
Drug Delivery: Injection Devices - Product Thumbnail Image

Drug Delivery: Injection Devices

  • Newsletter
  • August 2026
  • 58 Pages
  • Global
Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules - Product Thumbnail Image

Kratom Industry Offers Own Standards As Another Firm Warned About FDA Rules

  • Newsletter
  • August 2026
  • 3 Pages
  • Global
From
Real-World Evidence: US FDA's Prucalopride Review Shows Datasets' Utility And Limitations - Product Thumbnail Image

Real-World Evidence: US FDA's Prucalopride Review Shows Datasets' Utility And Limitations

  • Newsletter
  • August 2026
  • 4 Pages
  • United States
From
FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework - Product Thumbnail Image

FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework

  • Newsletter
  • August 2026
  • 3 Pages
  • Global
From
Roche's External Control Arms Show What Real-World Evidence Can Look Like In Practice - Product Thumbnail Image

Roche's External Control Arms Show What Real-World Evidence Can Look Like In Practice

  • Newsletter
  • August 2026
  • 4 Pages
  • Global
From
It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims - Product Thumbnail Image

It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims

  • Newsletter
  • August 2026
  • 3 Pages
  • Global
From
Loading Indicator